21hon MSN
Gene-edited babies are now closer to becoming a reality. The ethical debate is far from settled
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results